Skip to main content

Animations

Nir Giladi, MD

Professor of Neurology, Director of the Brain Division at Tel Aviv Sourasky Medical Center

Associate Dean

Incumbent of the Sieratzki Chair in Neurology

Director Aufzien Center for Treatment and Prevention of Parkinson's disease, School of Medicine, Sagol School of Neuroscience

Location: Tel Aviv Israel

Professor Nir Giladi is an internationally recognized neurologist and opinion leader in the field of movement disorders, particularly Parkinson's disease (PD), gait and dystonia, genetic and epidemiological aspects of movement disorders and aging. As director of the Brain Division and past chairman of the Neurological Institute at Tel Aviv Medical Center (2007-2022), he lead dozens of translational research projects yearly, and has access to a very large patient pool, as well as medical facilities and infrastructure. In addition to multiple clinical trials at stages I-IV, the Neurological Institute is involved in basic research, mainly in neuroimmunology, neurogenetics, cognitive neurosciences, neuroimaging and neurophysiology. Since 2007, Prof. Giladi has concentrated on translational research in all sub-disciplines of neurology. He has published more than 400 original papers in peer-reviewed journals and his h-index based on Google Scholar in December 2022 is 117, with i10 index 412 and citation index 54805.


Associated Grants

  • Developing a Novel Platform for Patient Selection and Disease Tracking Using Super-resolution Microscopy and AI

    2023


  • Alpha-synuclein and Other Biomarkers in Biological Samples of LRRK2 Parkinson’s Disease

    2013


  • Cortical and Subcortical Changes in Non-manifesting Carriers of the G2019S Mutation in the LRRK2 Gene

    2013


  • Gait and Motor Symptoms in Healthy Asymptomatic Relatives of Patients with PD Who Are Carriers of Mutations in the LRRK2 Gene

    2011


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.